AIMS Genetics (Sep 2019)

Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety

  • Sharvesh Raj Seeruttun

DOI
https://doi.org/10.3934/genet.2019.3.64
Journal volume & issue
Vol. 6, no. 3
pp. 64 – 66

Abstract

Read online

No abstracts available.